Forte Biosciences, Inc. — Director's Dealing 2017

Dec 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tocagen Inc (TOCA)
CIK: 0001419041
Period of Report: 2017-12-08

Reporting Person: Jolly Douglas (EVP, Research & Pharm Devel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-08	Common Stock	J	739	$8.50	Acquired	392043	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	21739	Indirect
Common Stock	21739	Indirect

Footnotes

F1: This Form 4 is being filed voluntarily to report the acquisition of 739 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan.

F2: The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.